Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Cash from Investing Activities (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Cash from Investing Activities for 14 consecutive years, with -$11.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 81.6% to -$11.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.8 million through Dec 2025, up 139.28% year-over-year, with the annual reading at $69.8 million for FY2025, 139.28% up from the prior year.
  • Cash from Investing Activities hit -$11.8 million in Q4 2025 for Corcept Therapeutics, down from $14.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $207.5 million in Q1 2023 to a low of -$109.6 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged $242950.0 across 5 years, with a median of -$10.4 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: soared 1151.97% in 2021 and later plummeted 2187.47% in 2023.
  • Year by year, Cash from Investing Activities stood at $140.5 million in 2021, then plummeted by 112.27% to -$17.2 million in 2022, then skyrocketed by 199.17% to $17.1 million in 2023, then plummeted by 476.42% to -$64.4 million in 2024, then soared by 81.6% to -$11.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CORT at -$11.8 million in Q4 2025, $14.6 million in Q3 2025, and $70.1 million in Q2 2025.